Despite the dramatic decrease in HIV-associated neurocognitive impairment (NCI) in the
combined antiretroviral treatment (cART) era, subtler neuropsychological complications …

Purpose of the review By reviewing the most recent common mental health disorders
(CMHD) studies in people living with HIV (PLWH)(2018-2020), this review discusses the …

Modern antiretroviral therapy (ART) has increased longevity of people with HIV and shifted
the age distribution of the HIV pandemic upward toward that of the general population. This …

Background HIV-related neuroinflammation has been proposed as a catalyst for
dopaminergic dysregulation in mesocortical pathways, which may contribute to the …

Objective: Methamphetamine and cannabis are two widely used substances among people
living with HIV (PLWH). Whereas methamphetamine use has been found to worsen HIV …

We examined the joint effects of depressive symptoms (Beck Depression Inventory-II (BDI-
II)) and systemic inflammation (plasma C-reactive protein (CRP)) on longitudinal profiles of …

Hypertension is one of the most prevalent chronic conditions and has been proven to be
related to cognitive function. However, there is no evidence regarding the heterogeneity in …

Nowadays, HIV infection is largely considered as a chronic condition rather than a deadly
disease, given that effective antiretroviral treatment allows almost complete and persistent …

Depressive symptoms are more prevalent in persons with HIV (PWH) than HIV‐uninfected
individuals. In HIV‐uninfected individuals, depression has been associated with atrophy in …

The current chapter provides a critical and narrative review of recent research on the
neuropsychiatric disorders, emotional disturbances, and their associations with …